Bernhardt, B., Weigel, B. J. (2026). Pediatric-Friendly Formulations: Critical to Maximizing Benefit of Novel Therapeutics Such as Selumetinib for Children With Neurofibromatosis and Other Neoplasms. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02765